Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Daniela Barlocco"'
Autor:
Fiorella Meneghetti, Daniela Barlocco
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 370 (2024)
This Special Issue contains 16 original articles, 3 reviews, and 1 communication [...]
Externí odkaz:
https://doaj.org/article/d8c41657bff740f19ab47748f18e64e7
Autor:
Laurent R. Chiarelli, Matteo Mori, Giangiacomo Beretta, Arianna Gelain, Elena Pini, Josè Camilla Sammartino, Giovanni Stelitano, Daniela Barlocco, Luca Costantino, Margherita Lapillo, Giulio Poli, Isabella Caligiuri, Flavio Rizzolio, Marco Bellinzoni, Tiziano Tuccinardi, Stefania Villa, Fiorella Meneghetti
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 823-828 (2019)
Starting from the analysis of the hypothetical binding mode of our previous furan-based hit (I), we successfully achieved our objective to replace the nitro moiety, leading to the disclosure of a new lead exhibiting a strong activity against MbtI. Ou
Externí odkaz:
https://doaj.org/article/6ba177ad0ffa4fc28c89f33af7982d70
Autor:
Fiorella Meneghetti, Daniela Barlocco
Publikováno v:
Pharmaceuticals, Vol 14, Iss 4, p 382 (2021)
This Special Issue of Pharmaceuticals is devoted to significant advances achieved in the field of antibacterial agents [...]
Externí odkaz:
https://doaj.org/article/b19c228d5c1544e5bdb1b4bbb86d2f43
Autor:
Matteo Mori, Giovanni Stelitano, Laurent R. Chiarelli, Giulia Cazzaniga, Arianna Gelain, Daniela Barlocco, Elena Pini, Fiorella Meneghetti, Stefania Villa
Publikováno v:
Pharmaceuticals, Vol 14, Iss 2, p 155 (2021)
Tuberculosis (TB) causes millions of deaths every year, ranking as one of the most dangerous infectious diseases worldwide. Because several pathogenic strains of Mycobacterium tuberculosis (Mtb) have developed resistance against most of the establish
Externí odkaz:
https://doaj.org/article/9b85a7096bf347e7aa5d0a78f21d473e
Autor:
Elena Gabriele, Federica Porta, Giorgio Facchetti, Corinna Galli, Arianna Gelain, Fiorella Meneghetti, Isabella Rimoldi, Sergio Romeo, Stefania Villa, Chiara Ricci, Nicola Ferri, Akira Asai, Daniela Barlocco, Anna Sparatore
Publikováno v:
ARKIVOC, Vol 2017, Iss 2, Pp 235-250 (2016)
Externí odkaz:
https://doaj.org/article/a0d0c5245f56486fb90d1a32e145ee4f
Autor:
Elena Pini, Giulio Poli, Tiziano Tuccinardi, Laurent Roberto Chiarelli, Matteo Mori, Arianna Gelain, Luca Costantino, Stefania Villa, Fiorella Meneghetti, Daniela Barlocco
Publikováno v:
Molecules, Vol 23, Iss 7, p 1506 (2018)
Tuberculosis is the leading cause of death from a single infectious agent worldwide; therefore, the need for new antitubercular drugs is desperate. The recently validated target salicylate synthase MbtI is the first enzyme involved in the biosynthesi
Externí odkaz:
https://doaj.org/article/9ae7d197351a4e6e8bd277cbc651bdc8
Autor:
Daniela Barlocco, Fiorella Meneghetti
Publikováno v:
Molecules, Vol 22, Iss 7, p 1127 (2017)
Since the discovery of Penicillin, antibiotics have saved millions of lives every year.[...]
Externí odkaz:
https://doaj.org/article/6d646763d1c245f0aae7c36d2f0943d8
Autor:
Eftiola Pojani, Daniela Barlocco
Publikováno v:
Current Medicinal Chemistry. 29:2306-2321
Histone acetylation balance is one epigenetic mechanism controlling gene expression associated with disease progression. It has been observed that histone deacetylase 10 (HDAC-10) isozyme contributes to the chemotherapy resistance; in addition, the p
Autor:
Daniela Barlocco, Luca Costantino
Publikováno v:
Journal of Chemical Education. 96:888-894
This article presents the structure of the organic chemistry laboratory Course “Synthesis and Extraction of Drugs” that is included in Modena University (Italy) in the third year of the five-year “Chemistry and Pharmaceutical Technologies” de
Autor:
Daniela Barlocco, Fiorella Meneghetti
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 382, p 382 (2021)
Pharmaceuticals, Vol 14, Iss 382, p 382 (2021)
This Special Issue of Pharmaceuticals is devoted to significant advances achieved in the field of antibacterial agents. Here, we report recent efforts made to develop new antimicrobials with novel modes of action/resistance, and offer perspectives on